[{"data":1,"prerenderedAt":140},["ShallowReactive",2],{"drug-epinastine-eye":3},{"id":4,"schemaVersion":5,"name":6,"category":9,"class":10,"brands":13,"synonyms":17,"formulations":21,"regimens":34,"contraindications":50,"warnings":51,"renal":59,"monitoring":60,"interactions":61,"review":62,"examples":65,"atc":71,"iran":73,"links":85,"populations":100,"usApproval":135},"epinastine-eye",1,{"fa":7,"en":8},"قطره چشمی اپیناستین","Epinastine eye drops","sensory-organs",{"fa":11,"en":12},"آنتی‌هیستامین چشمی","Ophthalmic antihistamine",[14],{"name":15,"market":16},"Elestat","US",[18,19,20],"elestat","relestat","اپیناستین",[22],{"id":23,"form":24,"route":25,"label":26,"concentration":27,"markets":29,"refs":30},"drops","eye-drops","ophthalmic","0.05% ophthalmic solution",{"amount":5,"unit":28,"perUnit":28},"drop",[16],[31],{"source":32,"section":33},"fda-epinastine","3",[35],{"id":36,"disease":37,"label":38,"population":41,"type":45,"unit":28,"dose":46,"refs":47},"ac","allergic-conjunctivitis",{"fa":39,"en":40},"خارش چشم آلرژیک — ۱ قطره هر چشم دو بار در روز (۲ سال به بالا)","Allergic itching — 1 drop each eye twice daily (≥2 y)",{"minAge":42},{"value":43,"unit":44},2,"year","fixed",{"perDose":5,"dosesPerDay":43},[48],{"source":32,"section":49},"2",[],[52],{"text":53,"refs":56},{"fa":54,"en":55},"برای سوزش ناشی از لنز استفاده نشود؛ لنز پیش از قطره برداشته شود.","Not for contact-lens irritation; remove lenses before use.",[57],{"source":32,"section":58},"5",[],[],[],{"status":63,"reviewer":64,"date":64},"unverified",null,[66],{"regimen":36,"formulation":23,"input":67,"expect":70},{"ageYears":68,"weightKg":69},20,60,{"perDose":5},[72],"S01GX10",{"status":74,"forms":75,"refs":80},"registered",[76],{"code":77,"en":78,"fa":79},"19515","EPINASTINE 0.5MG\u002FML OPH DROP","قطره چشمی اپیناستین ۰٫۵ میلی‌گرم \u002F میلی‌لیتر",[81],{"source":82,"section":83,"url":84},"darooyab-generic","G-798\u002FEpinastine-EENT","https:\u002F\u002Fwww.darooyab.ir\u002FG-798\u002FEpinastine-EENT",[86,90,94,97],{"kind":87,"url":88,"label":89},"fda","https:\u002F\u002Fwww.accessdata.fda.gov\u002Fscripts\u002Fcder\u002Fdaf\u002Findex.cfm?event=overview.process&ApplNo=090951","ANDA090951",{"kind":91,"url":92,"label":93},"dailymed","https:\u002F\u002Fdailymed.nlm.nih.gov\u002Fdailymed\u002FdrugInfo.cfm?setid=0d4ee45c-e58f-4b7c-b389-898f5c27f54d","FDA Epinastine eye",{"kind":95,"url":96,"label":72},"who-atc","https:\u002F\u002Fatcddd.fhi.no\u002Fatc_ddd_index\u002F?code=S01GX10",{"kind":98,"url":84,"label":99},"darooyab","Epinastine-EENT",{"pregnancy":101,"lactation":110,"pediatric":118,"geriatric":126},{"level":102,"text":103,"quote":106,"refs":107},"caution",{"fa":104,"en":105},"برچسب خطر مشخصی برای بارداری ذکر نکرده یا داده کافی ندارد؛ فقط در صورت لزوم و با نظر پزشک.","Label states no clear risk or has limited data; use only if needed, under medical advice.","Because animal reproduction studies are not always predictive of human response, epinastine HCl ophthalmic solution should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.",[108],{"source":32,"section":109},"8.1",{"level":102,"text":111,"quote":114,"refs":115},{"fa":112,"en":113},"برچسب: در شیردهی با احتیاط؛ متن برچسب را ببینید.","Label: use with caution while breastfeeding; see the label text.","Because many drugs are excreted in human milk, caution should be exercised when epinastine HCl ophthalmic solution is administered to a nursing woman.",[116],{"source":32,"section":117},"8.3",{"level":102,"text":119,"quote":122,"refs":123},{"fa":120,"en":121},"برچسب برای کودکان شرط، محدودیت سنی یا نکته دارد؛ جمله برچسب در زیر آمده است.","The label has conditions, age limits or notes for children; the label sentence is quoted below.","Safety and effectiveness in pediatric patients below the age of 2 years have not been established.",[124],{"source":32,"section":125},"8.4",{"level":127,"text":128,"quote":131,"refs":132},"ok",{"fa":129,"en":130},"برچسب: در سالمندان تفاوت یا تنظیم دوز خاصی ذکر نشده.","Label: no specific difference or dose adjustment stated for older adults.","No overall differences in safety or effectiveness have been observed between elderly and younger patients.",[133],{"source":32,"section":134},"8.5",{"kind":136,"refs":137,"id":89},"ANDA",[138],{"source":32,"section":139},"SPL approval \u002F marketing category",1792100105810]